Back

Anatomical-based percutaneous left stellate ganglion block in patients with refractory electrical storm: efficacy and safety.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome? Drug Treatment of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Sara Compagnoni

University of Pavia, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
Post-infarct VT substrate ablation based on evoked delayed potential elimination as well-defined target: results from a prospective multicenter study.
Doctor M. De Riva Silva (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Stellate ganglion blockade for treatment of ventricular arrhythmia storm: A meta-analysis
Doctor S. Zafeiropoulos (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Long-term toxicity of radiosurgery for ablation of ventricular tachycardia
Mr J. Cvek (Ostrava, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Effects of percutaneous left stellate ganglion block on heart rate variability in patient with electrical storm after myocardial infarction.
thumbnail
Congress Presentation
Percutaneous left stellate ganglion block for a refractory left atrial tahycardia
thumbnail
Congress Presentation
Clinical determinants of percutaneous stellate ganglion block (PSGB) effectiveness in patients with electrical storm

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources